New “Working Group on Cardiovascular Pharmacotherapy and Adherence” of the European Society of Hypertension

The European Society of Hypertension (ESH) has decided to establish a new Working Group (WG) on the topic of “Cardiovascular Pharmacotherapy and Adherence”. This decision is based on the growing evidence that poor adherence to treatment is a major cause of poor blood pressure control.

We are very pleased to announce that our recent ESH 2019 Summer School with 65 participants in Vravrona (Greece) held from September 15 to 19, was a great success.

Once again, the ESH Summer School reached its main goal to be a networking, educative and innovative experience. Insightful presentations, interactive discussions and clinical take-home messages for the young participants was a must.

Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres, dedicated to Professor Alberto Zanchetti.
The most important task of the European Society of Hypertension is to improve blood pressure treatment and increase blood pressure control, thus decreasing cardiovascular risk, premature cardiovascular and renal morbidity and mortality, with in addition a reduction of health-care costs.

The new “2018 European Society of Cardiology (ESC) and European Society of Hypertension (ESH) Guidelines for the management of arterial hypertension” are available for you here.
The development of the guidelines was led by Prof. Bryan Williams (ESC Chairperson), London UK, and Prof. Giuseppe Mancia (ESH Chairperson), Milan Italy, as lead authors.